Reference
PHARMAC. Proposal relating to pembrolizumab (Keytruda), nivolumab (Opdivo), posaconazole (Noxafil) and raltegravir (Isentress). Internet Document : 28 Jun 2016. Available from: URL: https://www.pharmac.govt.nz/news/consultation-2016-06-28-pembrolizumab-nivolumab-posaconazole-raltegravir/
Rights and permissions
About this article
Cite this article
PHARMAC seeks feedback on proposals for pembrolizumab . . .. PharmacoEcon Outcomes News 756, 39 (2016). https://doi.org/10.1007/s40274-016-3188-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3188-9